Your browser doesn't support javascript.
loading
Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.
Chen, An; Lan, Zirong; Li, Li; Xie, Luting; Liu, Xiaoyu; Yang, Xiulin; Wang, Siyi; Liang, Qingchun; Dong, Qianqian; Feng, Liyun; Li, Yining; Ye, Yuanzhi; Fu, Mingwei; Lu, Lihe; Yan, Jianyun.
Afiliação
  • Chen A; Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Lan Z; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Li L; Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Xie L; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Liu X; Department of Cardiology, Guangzhou Red Cross Hospital, Jinan University, 396 Tongfu Middle Road, Guangzhou, 510220, China.
  • Yang X; Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Wang S; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Liang Q; Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Dong Q; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Feng L; Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Li Y; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Ye Y; Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Fu M; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, 253 Industrial Avenue, Guangzhou, 510280, China.
  • Lu L; Department of Anesthesiology, The Third Affiliated Hospital, Southern Medical University, 183 West Zhongshan Avenue, Guangzhou, 510630, China.
  • Yan J; Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, 510280, China.
Cardiovasc Res ; 119(13): 2368-2381, 2023 10 24.
Article em En | MEDLINE | ID: mdl-37523743

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica / Calcificação Vascular Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica / Calcificação Vascular Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article